Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The results of the Evaluation of LIXisenatide in Acute coronary syndrome (ELIXA) trial, the first cardiovascular outcomes trial for the short-acting GLP-1 RA lixisenatide, were also published recently [52]
Ventegra's 20252026 Managed Care Fellow, Sara Chea, PharmD, analyzed real-world pharmacy claims data for three guideline-recommended #CGRP therapiesrimegepant, ubrogepant, and zavegepant
Versatile, high-resolution anterograde labeling of vagal efferent projections with dextran amines
Barnes LL
129 Molecular, cellular, electrophysiological, and behavioural abnormalities in accordance with autism-like phenotypes in several Wnt signalling-related knockout mouse models
US$ 24.19
US$ 21.71
US$ 22.80
US$ 21.01
